当前位置: X-MOL 学术Ophthalmology › 论文详情
Our official English website, www.x-mol.net, welcomes your feedback! (Note: you will need to create a separate account there.)
Teprotumumab for Asymmetric Thyroid Eye Disease.
Ophthalmology ( IF 13.1 ) Pub Date : 2021-10-01 , DOI: 10.1016/j.ophtha.2021.03.004
Shoaib Ugradar 1 , Yao Wang 2 , Raymond Douglas 2
Affiliation  



中文翻译:

Teprotumumab 用于非对称性甲状腺眼病。

更新日期:2021-09-25
down
wechat
bug